• UK Agency Grants Raxone Temporary Approval to Treat Certain DMD Patients
  • Sarepta and Genethon Will Collaborate to Develop DMD Gene Therapy
  • A Look Inside the Muscular Dystrophy Association’s Summer Camps
  • What Is Facioscapulohumeral Muscular Dystrophy?
  • Nuclear Receptor REV-ERB May be Targeted to Improve Muscle Tissue Regeneration Mechanism, Study Finds
  • FDA Grants RASRx1902 Orphan Drug Status as Potential Therapy for Duchenne Muscular Dystrophy
  • Simultaneously Inhibiting Three Proteins Can Increase Muscle Mass in Mice with Muscular Dystrophy, Study Shows
  • 9 Areas of Research for Duchenne Muscular Dystrophy
  • June 20, World FSHD Day, Aims to Raise Awareness of Facioscapulohumeral Muscular Dystrophy
  • Small Town Helping Young Man With Duchenne See Australia
  • Inspirational People With Muscular Dystrophy: Robert Watson
  • Former Cancer Therapy Candidate Improves Muscle Function in Duchenne MD Mice